WS #13275
FT reports AstraZeneca in talks with Bristol Myers Squibb on $400B megadeal, one of largest in history.
AstraZeneca-Bristol Myers merger talks
FT reports AstraZeneca in talks with Bristol Myers Squibb on $400B megadeal, one of largest in history.